日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Desulfovibrio desulfuricans 30S ribosomal protein S10 (rpsJ) CSB-YP491440DJN
CSB-EP491440DJN
CSB-BP491440DJN
CSB-MP491440DJN
CSB-EP491440DJN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Desulfovibrio desulfuricans 30S ribosomal protein S3 (rpsC) CSB-YP491441DJN
CSB-EP491441DJN
CSB-BP491441DJN
CSB-MP491441DJN
CSB-EP491441DJN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Glutamyl-Q tRNA (Asp) synthetase CSB-YP491442EZY
CSB-EP491442EZY
CSB-BP491442EZY
CSB-MP491442EZY
CSB-EP491442EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Dihydrodipicolinate reductase (dapB) CSB-YP491443EZY
CSB-EP491443EZY
CSB-BP491443EZY
CSB-MP491443EZY
CSB-EP491443EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa NH (3)-dependent NAD (+) synthetase CSB-YP491444EZY
CSB-EP491444EZY
CSB-BP491444EZY
CSB-MP491444EZY
CSB-EP491444EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa DNA mismatch repair protein mutL (mutL), partial CSB-YP491445EZY
CSB-EP491445EZY
CSB-BP491445EZY
CSB-MP491445EZY
CSB-EP491445EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa RNA pyrophosphohydrolase (rppH) CSB-YP491446EZY
CSB-EP491446EZY
CSB-BP491446EZY
CSB-MP491446EZY
CSB-EP491446EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Probable D-serine dehydratase (dsdA) CSB-YP491447EZY
CSB-EP491447EZY
CSB-BP491447EZY
CSB-MP491447EZY
CSB-EP491447EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Phosphomethylpyrimidine synthase (thiC), partial CSB-YP491448EZY
CSB-EP491448EZY
CSB-BP491448EZY
CSB-MP491448EZY
CSB-EP491448EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa ATP-dependent protease subunit HslV (hslV) CSB-YP491449EZY
CSB-EP491449EZY
CSB-BP491449EZY
CSB-MP491449EZY
CSB-EP491449EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Imidazolonepropionase (hutI) CSB-YP491450EZY
CSB-EP491450EZY
CSB-BP491450EZY
CSB-MP491450EZY
CSB-EP491450EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Phosphoenolpyruvate carboxykinase [ATP] (pckA), partial CSB-YP491451EZY
CSB-EP491451EZY
CSB-BP491451EZY
CSB-MP491451EZY
CSB-EP491451EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Putative Holliday junction resolvase (PLES_04021) CSB-YP491452EZY
CSB-EP491452EZY
CSB-BP491452EZY
CSB-MP491452EZY
CSB-EP491452EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa S-adenosylmethionine synthase (metK) CSB-YP491453EZY
CSB-EP491453EZY
CSB-BP491453EZY
CSB-MP491453EZY
CSB-EP491453EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa UPF0229 protein PLES_05841 (PLES_05841) CSB-YP491454EZY
CSB-EP491454EZY
CSB-BP491454EZY
CSB-MP491454EZY
CSB-EP491454EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa UvrABC system protein C (uvrC), partial CSB-YP491455EZY
CSB-EP491455EZY
CSB-BP491455EZY
CSB-MP491455EZY
CSB-EP491455EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Xanthine phosphoribosyltransferase (xpt) CSB-YP491456EZY
CSB-EP491456EZY
CSB-BP491456EZY
CSB-MP491456EZY
CSB-EP491456EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP491457EZY
CSB-EP491457EZY
CSB-BP491457EZY
CSB-MP491457EZY
CSB-EP491457EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa Indole-3-glycerol phosphate synthase (trpC) CSB-YP491458EZY
CSB-EP491458EZY
CSB-BP491458EZY
CSB-MP491458EZY
CSB-EP491458EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas aeruginosa 50S ribosomal protein L10 (rplJ) CSB-YP491459EZY
CSB-EP491459EZY
CSB-BP491459EZY
CSB-MP491459EZY
CSB-EP491459EZY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×